Geneva Partners’s HealthEquity HQY Stock Holding History

Geneva Partners’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,040	Closed	-$665K	–	68
2018 Q3	$665K	Sell	7,040 -1,280	-15%	-$110K	0.51%	58
2018 Q2	$625K	Sell	8,320 -6,085	-42%	-$437K	0.5%	58
2018 Q1	$872K	Buy	+14,405	New	+$780K	0.72%	46

Other funds holding HQY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geneva Partners's HQY Position: Q4 2018 in Review

Geneva Partners sold out of HealthEquity (HQY) in Q4 2018, closing a stake of 7,040 shares — an estimated $665K sold.

Geneva Partners first reported a position in HQY in Q1 2018 and held it in 3 quarters. The position peaked at $872K in Q1 2018. 310 funds tracked by Wall St. Rank hold HQY as of Q4 2018.

Geneva Partners reported no remaining HealthEquity position as of Q4 2018 after selling out during the quarter.
Geneva Partners sold 7,040 HealthEquity shares in Q4 2018, an estimated $665K.
Geneva Partners first reported a position in HealthEquity in Q1 2018 and held it in 3 quarters.
Geneva Partners's HealthEquity position peaked at $872K in Q1 2018.
310 funds tracked by Wall St. Rank held HealthEquity as of Q4 2018.

Based on Geneva Partners's 13F filing for Q4 2018, filed 30 Jan 2019.